Anti-PDL1, IL-15 and TGF-beta receptor combination molecules
US11168138B2 · kind B2 · utility
14Cited by
4References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 26, 2019 |
| Grant date | Nov 9, 2021 |
| Priority date | — |
| Expiry date | Jul 4, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features multi-specific protein complexes with one domain comprising IL-15 or a functional variant, a cytokine receptor or cytokine ligand, and a binding domain specific to a disease antigen, immune checkpoint or signaling molecule.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.